article thumbnail

The American Journal of Psychiatry’s Answer to MIA: A Silence that Speaks Volumes

Mad in America

O n September 9, Mad in America set up a petition on change.org urging the American Journal of Psychiatry to retract its 2006 article that told of a 67% remission rate in the STAR*D trial. At that time, we put up a petition on change.org urging that the Am J of Psychiatry retract the 2006 article. Mad in America, a U.S.

article thumbnail

Observational Studies Confirm Trial Results That Antidepressants Double Suicides

Mad in America

One would have thought that suicide is a hard endpoint and that we can believe analyses carried out by drug regulators based on the clinical study reports the manufacturers have submitted to them, but this is not so. FDA 2006; Nov 16. Restoring the two pivotal fluoxetine trials in children and adolescents with depression.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Journals Refuse to Retract Fraudulent Trial Reports That Omitted Suicidal Events in Children

Mad in America

We cited research based on the clinical study reports the manufactures had submitted to drug regulators to get their drugs approved for children and adolescents and other research in our letter. 4,5 I asked Emslie and the manufacturer, Eli Lilly, if they wanted to restore the trials. FDA 2006;Nov 16. The fraud was grave.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

A 2006 National Institute of Mental Health (NIMH) study, “ The Naturalistic Course of Major Depression in the Absence of Somatic Therapy ,” examined depressed patients who had recovered from an initial episode of depression, then relapsed but did not take any medication following their relapse.

article thumbnail

The Iatrogenic Gaze: How We Forgot That Psychiatry Could Be Harmful

Mad in America

That rate has been increasing rapidly: “From 2006 to 2014, the number of serious ADEs reported to the FDA increased 2-fold… A previously published study… found that from 1998 to 2005, there was a 2.6-fold This move “transformed pharmaceutical outfits into companies who market drugs rather than companies who manufacture drugs for the market.”

article thumbnail

MindFreedom’s Shield Program: Working to Free People from Psychiatric Incarceration and Forced Treatment

Mad in America

While the ongoing logistics of maintaining such a network have proved challenging, one such successful effort in 2006 was documented in The Wall Street Journal. Somatics LLC marked a watershed moment for advocates who have fought for decades for ECT device manufacturer accountability.

Legal 137
article thumbnail

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

Bristol Myers, along with the many other manufacturing plants located in the surrounding area, helped to grow and strengthen our local economy. By the mid-2000s, because of cheaper costs to manufacture penicillin in foreign countries, the plant downsized considerably. She was four years old.